| 8.34 Delayed Data As of Mar 04 |  -0.07 / -0.83%Today’s Change | 6.02 Today|||52-Week Range 18.99 | +15.83% Year-to-Date |
| Previous close | 8.41 |
| Today’s open | 8.41 |
| Day’s range | 8.09 - 8.41 |
| Volume | 26,057 |
| Average volume (3 months) | 30,442 |
| Market cap | $158.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -272.73% |
| Earnings growth (this year) | +95.08% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -73.83% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 54.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| INNLInnocoll AG | -0.49 | -6.13% |
| ASMBAssembly Biosciences... | -0.52 | -3.51% |
| CRMECardiome Pharma Corp | -0.11 | -1.11% |
| MDWDMediwound Ltd | +0.27 | +3.54% |
| Last reporting date | March 5, 2015 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$10.6M |
| Net profit margin | -265.63% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
Chief Financial Officer & Head-Media Relations Brian M. Hahn |
Corporate headquarters Gaithersburg, Maryland |
